Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Bayer : Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 45596) - Meeting

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/02/2017 | 07:44pm CEST

TIME: 8:30 a.m.

EVENT: Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 45596) holds a meeting of the Antimicrobial Drugs Advisory Committee to discuss new drug application 209367, ciprofloxacin inhalation powder, sponsored by Bayer HealthCare Pharmaceuticals, Inc., for the proposed indication of reduction of exacerbations in non-cystic fibrosis bronchiectasis adult patients with respiratory bacterial pathogens.

DATE: November 16, 2017

LOCATION: FDA White Oak Campus, 10903 New Hampshire Avenue, Building 31 Conference Center, the Great Room, Room 1503, Silver Spring, Md.

CONTACT: Lauren Tesh, 301-796-9001, [email protected]

Copyright (c) 2017 Federal Information & News Dispatch, Inc., source Washington Daybook

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
04/20MONSANTO : Russian nod moves Bayer closer to wrapping up Monsanto deal
RE
04/20BAYER : Gains Russian Approval for Monsanto Deal
DJ
04/20BAYER : Temasek subscribes to capital increase and acquires approximately 3.6 pe..
AQ
04/20RUSSIA GIVES GREEN LIGHT TO BAYER'S : Ifax
RE
04/18BAYER AKTIENGESELLSCHAFT : Release according to Article 41 of the WpHG [the Germ..
EQ
04/18BAYER : commits to provide innovative vector control solutions to help eradicate..
PU
04/17EASTON PHARMACEUTICALS : Announces BAYER Agreement Update
AQ
04/17BAYER : Shareholder Temasek to Increase Share Capital -- Update
DJ
04/17BAYER : Temasek subscribes to capital increase and acquires approximately 3.6 pe..
AQ
More news
News from SeekingAlpha
04/23OAKMARK INTERNATIONAL FUND : Q1 2018 
04/23OAKMARK GLOBAL FUND : Q1 2018 
04/20Bayer wins Russian approval for Monsanto deal 
04/17Germany to go forward with plans to restrict Monsanto weedkiller 
04/17Bayer's ILDR2 inhibitor shows encouraging action in preclinical studies, disc.. 
Financials (€)
Sales 2018 35 542 M
EBIT 2018 7 319 M
Net income 2018 4 811 M
Debt 2018 6 823 M
Yield 2018 2,85%
P/E ratio 2018 17,87
P/E ratio 2019 15,58
EV / Sales 2018 2,50x
EV / Sales 2019 2,33x
Capitalization 81 868 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 118 €
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-4.81%100 586
JOHNSON & JOHNSON-9.35%339 783
PFIZER1.13%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%191 890
MERCK AND COMPANY4.55%158 571